MedTrace Logo

Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis

NCT05247710 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-07-06

No results posted yet for this study

Summary

The trial is a single-center, non-randomized feasibility study aiming to evaluate the feasibility of ex-vivo tissue analysis using differential mobility spectrometry (DMS) of tissue smoke generated by the use of an electrosurgical instrument.

Patients recruited in the trial receive standard-of-care basal cell carcinoma tumor excision surgery.

Conditions

Interventions

PROCEDURE

Punch biopsy

Punch biopsy of basal cell carcinoma tumor and a control biopsy of healthy skin are collected during primary tumor excision surgery from each recruited patient.

Sponsors & Collaborators

  • Olfactomics Oy

    collaborator UNKNOWN

  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Niku Oksala, M.D., Ph.D. · Tampere University Hospital

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2023-12-31
Completion
2024-06-30

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05247710 on ClinicalTrials.gov